...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: OTC Expert & Grey Market Restrictions
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Cottonmouth, were they able to tell you how many shares were available on the Ask?   Or is it a complete shot in the dark as to what is available, i.e. you are blind to both the standing best Ask order and how many shares are available at higher Ask prices?   


Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply